SeqOne Genomics Information

SeqOne is a leading and fast-growing clinical genomics company committed to making ing personalized medicine a reality for every patient. Our AI-powered NGS platform and expert services help molecular laboratories turn genomic data into clinical answers faster, supporting variant interpretation and reporting across rare and inherited diseases, oncology, preventive genomics, and infectious diseases. Founded in 2017, SeqOne is IVDR certified and used by public and private labs and national genomic programs in over 35 countries. Learn more at [seqone.com](http://seqone.com/). The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.